Mallinckrodt jumps 9% after drugmaker beats first-quarter earnings estimates, raises 2019 profit outlook

Mallinckrodt Pharmaceuticals soared in premarket trading Tuesday after the company released first-quarter earnings that beat Wall Street's expectations and raised its profit outlook for the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.